Lifeway Foods (LWAY) Financials

$24.21 -1.79 (-6.88%)

Closing price 05/15/2026 04:00 PM Eastern

Extended Trading

$24.18 -0.03 (-0.12%)

As of 05/15/2026 04:20 PM Eastern

Annual Income Statements for Lifeway Foods

This table shows Lifeway Foods' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	0.92	11	9.03
Consolidated Net Income / (Loss)	0.92	11	9.03
Net Income / (Loss) Continuing Operations	0.92	11	9.03
Total Pre-Tax Income	1.84	17	14
Total Operating Income	2.35	17	14
Total Gross Profit	27	42	49
Total Revenue	142	160	187
Operating Revenue	142	160	187
Total Cost of Revenue	115	118	138
Operating Cost of Revenue	115	118	138
Total Operating Expenses	24	25	35
Selling, General & Admin Expense	24	25	34
Amortization Expense	0.54	0.54	0.54
Total Other Income / (Expense), net	-0.51	-0.35	0.12
Interest Expense	0.27	0.38	0.11
Other Income / (Expense), net	-0.24	0.04	0.22
Income Tax Expense	0.92	5.28	4.94
Basic Earnings per Share	$0.06	$0.77	$0.61
Weighted Average Basic Shares Outstanding	15.40M	14.67M	14.77M
Diluted Earnings per Share	$0.06	$0.75	$0.60
Weighted Average Diluted Shares Outstanding	15.72M	15.10M	15.13M
Weighted Average Basic & Diluted Shares Outstanding	14.64M	14.69M	15.20M

This table shows Lifeway Foods' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	0.98	0.72	0.83	3.16	3.41	3.97	2.43	3.78	2.98	-0.16
Consolidated Net Income / (Loss)	0.98	0.72	0.83	3.16	3.41	3.97	2.43	3.78	2.98	-0.16
Net Income / (Loss) Continuing Operations	0.98	0.72	0.83	3.16	3.41	3.97	2.43	3.78	2.98	-0.16
Total Pre-Tax Income	1.11	1.64	1.34	4.69	4.93	5.70	3.51	5.36	4.33	0.78
Total Operating Income	1.20	1.96	1.44	4.77	5.04	5.75	3.56	5.39	4.19	0.71
Total Gross Profit	7.59	7.92	8.23	11	11	12	12	13	12	12
Total Revenue	38	36	38	39	41	42	45	49	46	47
Operating Revenue	38	36	38	39	41	42	45	49	46	47
Total Cost of Revenue	31	28	30	28	30	30	33	36	34	35
Operating Cost of Revenue	31	28	30	28	30	30	33	36	34	35
Total Operating Expenses	6.39	5.96	6.79	6.51	6.10	6.04	7.97	7.89	7.68	11
Selling, General & Admin Expense	6.26	5.82	6.65	6.38	5.97	5.90	7.84	7.75	7.54	11
Amortization Expense	0.14	0.14	0.14	0.14	0.14	0.14	0.14	0.14	0.14	0.14
Total Other Income / (Expense), net	-0.08	-0.33	-0.10	-0.08	-0.11	-0.06	-0.06	-0.03	0.14	0.06
Interest Expense	0.08	0.10	0.10	0.11	0.11	0.06	0.05	0.05	0.00	0.00
Other Income / (Expense), net	-0.01	-0.23	0.01	0.03	-0.00	0.01	-0.01	0.02	0.14	0.07
Income Tax Expense	0.13	0.92	0.51	1.53	1.52	1.73	1.08	1.58	1.35	0.94
Basic Earnings per Share	$0.06	$0.05	$0.06	$0.22	$0.23	$0.26	$0.17	$0.26	$0.20	($0.02)
Weighted Average Basic Shares Outstanding	15.49M	15.40M	14.65M	14.65M	14.68M	14.67M	14.69M	14.73M	14.80M	14.77M
Weighted Average Diluted Shares Outstanding	15.85M	15.72M	15.03M	15.08M	15.10M	15.10M	15.22M	15.20M	15.27M	15.13M
Weighted Average Basic & Diluted Shares Outstanding	15.50M	14.64M	14.66M	14.67M	14.69M	14.69M	14.71M	14.79M	14.82M	15.20M

This table details how cash moves in and out of Lifeway Foods' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	-4.79	8.75	3.53
Net Cash From Operating Activities	3.99	17	13
Net Cash From Continuing Operating Activities	3.99	17	13
Net Income / (Loss) Continuing Operations	0.92	11	9.03
Consolidated Net Income / (Loss)	0.92	11	9.03
Depreciation Expense	2.97	3.16	3.39
Non-Cash Adjustments To Reconcile Net Income	1.36	1.47	2.47
Changes in Operating Assets and Liabilities, net	-1.27	0.94	-1.92
Net Cash From Investing Activities	-4.03	-4.41	-6.68
Net Cash From Continuing Investing Activities	-4.03	-4.41	-6.68
Purchase of Property, Plant & Equipment	-3.45	-4.35	-6.70
Purchase of Investments	0.00	-0.10	0.00
Sale of Property, Plant & Equipment	0.00	0.04	0.02
Net Cash From Financing Activities	-4.75	-3.78	-2.75
Net Cash From Continuing Financing Activities	-4.75	-3.78	-2.75
Repayment of Debt	-0.75	-3.78	-2.75
Cash Interest Paid	0.25	0.42	0.10
Cash Income Taxes Paid	1.12	4.79	5.99

This table details how cash moves in and out of Lifeway Foods' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	2.44	-4.49	0.77	2.24	5.18	0.57	-1.17	2.61	5.93	-3.83
Net Cash From Operating Activities	4.17	0.35	3.03	2.43	6.69	4.80	1.55	6.54	7.45	-2.58
Net Cash From Continuing Operating Activities	4.17	0.35	3.03	2.43	6.69	4.80	1.55	6.54	7.45	-2.58
Net Income / (Loss) Continuing Operations	0.98	0.72	0.83	3.16	3.41	3.97	2.43	3.78	2.98	-0.16
Consolidated Net Income / (Loss)	0.98	0.72	0.83	3.16	3.41	3.97	2.43	3.78	2.98	-0.16
Depreciation Expense	0.73	0.73	0.78	0.79	0.79	0.80	0.80	0.84	0.86	0.90
Non-Cash Adjustments To Reconcile Net Income	0.21	0.60	0.35	0.28	0.43	0.42	0.68	0.64	0.60	0.56
Changes in Operating Assets and Liabilities, net	2.25	-1.70	1.07	-1.80	2.06	-0.40	-2.35	1.28	3.02	-3.88
Net Cash From Investing Activities	-1.48	-0.84	-1.76	-0.19	-1.26	-1.20	-2.47	-1.44	-1.53	-1.25
Net Cash From Continuing Investing Activities	-1.48	-0.84	-1.76	-0.19	-1.26	-1.20	-2.47	-1.44	-1.53	-1.25
Purchase of Property, Plant & Equipment	-0.90	-0.84	-1.76	-0.23	-1.16	-1.21	-2.47	-1.44	-1.54	-1.25
Sale of Property, Plant & Equipment	-	-	-	-	-	0.00	-	-	0.01	0.00
Cash Interest Paid	0.07	0.09	0.13	0.11	0.11	0.07	0.05	0.04	0.01	0.00
Cash Income Taxes Paid	-	0.48	0.05	0.93	2.30	1.52	1.93	1.38	1.55	1.13

This table presents Lifeway Foods' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Total Assets	69	82	91
Total Current Assets	27	38	44
Cash & Equivalents	4.44	13	17
Accounts Receivable	11	14	15
Inventories, net	9.63	9.10	8.68
Prepaid Expenses	1.45	2.02	2.14
Current Deferred & Refundable Income Taxes	0.04	0.00	0.63
Plant, Property, & Equipment, net	21	23	27
Total Noncurrent Assets	21	21	20
Goodwill	12	12	12
Intangible Assets	7.44	6.90	6.36
Other Noncurrent Operating Assets	1.97	2.09	2.02
Total Liabilities & Shareholders' Equity	69	82	91
Total Liabilities	21	21	19
Total Current Liabilities	13	17	16
Short-Term Debt	1.25	1.25	0.00
Accounts Payable	7.98	9.98	10
Accrued Expenses	3.81	4.92	5.10
Current Deferred & Payable Income Tax Liabilities	0.00	0.47	0.00
Total Noncurrent Liabilities	8.39	4.60	3.13
Long-Term Debt	5.25	1.48	0.00
Noncurrent Deferred & Payable Income Tax Liabilities	3.03	3.00	3.06
Other Noncurrent Operating Liabilities	0.10	0.12	0.07
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	48	60	72
Total Preferred & Common Equity	48	60	72
Preferred Stock	0.00	0.00	0.00
Total Common Equity	48	60	72
Common Stock	10	11	11
Retained Earnings	54	66	75
Treasury Stock	-17	-17	-14

This table presents Lifeway Foods' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	74	71	72	80	83	85	91
Total Current Assets	32	28	30	37	38	39	45
Cash & Equivalents	8.93	5.21	7.45	13	12	15	21
Accounts Receivable	12	12	11	13	15	15	13
Inventories, net	9.19	9.29	9.67	9.32	8.13	8.45	8.44
Prepaid Expenses	1.37	1.07	1.21	1.62	1.99	1.49	1.89
Current Deferred & Refundable Income Taxes	0.65	0.00	0.00	0.26	0.38	0.18	0.38
Plant, Property, & Equipment, net	21	22	22	22	25	25	26
Total Noncurrent Assets	21	21	21	21	21	20	20
Goodwill	12	12	12	12	12	12	12
Intangible Assets	7.57	7.30	7.17	7.03	6.76	6.63	6.49
Other Noncurrent Operating Assets	1.94	1.95	1.94	2.10	2.07	2.05	2.04
Total Liabilities & Shareholders' Equity	74	71	72	80	83	85	91
Total Liabilities	23	22	20	24	19	17	20
Total Current Liabilities	14	14	12	16	15	14	17
Short-Term Debt	1.00	1.00	1.25	1.25	1.25	0.00	0.00
Accounts Payable	9.12	9.15	5.57	9.10	10	9.37	11
Accrued Expenses	4.38	3.23	4.29	5.56	3.60	4.49	5.59
Current Deferred & Payable Income Tax Liabilities	0.00	0.42	1.02	0.50	0.00	0.00	0.00
Total Noncurrent Liabilities	8.78	8.12	7.86	7.67	4.34	3.09	3.08
Long-Term Debt	5.50	5.01	4.76	4.51	1.24	0.00	0.00
Noncurrent Deferred & Payable Income Tax Liabilities	3.20	3.03	3.03	3.03	3.00	3.00	3.00
Other Noncurrent Operating Liabilities	0.07	0.09	0.07	0.13	0.10	0.09	0.08
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	50	49	52	56	64	68	72
Total Preferred & Common Equity	50	49	52	56	64	68	72
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	50	49	52	56	64	68	72
Common Stock	9.78	10	11	11	12	12	12
Retained Earnings	54	55	58	62	68	72	75
Treasury Stock	-13	-17	-17	-17	-17	-16	-16

This table displays calculated financial ratios and metrics derived from Lifeway Foods' official financial filings.

Metric	2022	2023	2024
Period end date	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-
Revenue Growth	18.90%	13.11%	16.67%
EBITDA Growth	-40.96%	297.54%	-13.54%
EBIT Growth	-63.22%	708.02%	-17.37%
NOPAT Growth	-65.99%	884.19%	-22.87%
Net Income Growth	-72.09%	1,130.19%	-20.60%
EPS Growth	-71.43%	1,150.00%	-20.00%
Operating Cash Flow Growth	-28.34%	324.91%	-23.49%
Free Cash Flow Firm Growth	34.12%	962.32%	-66.81%
Invested Capital Growth	5.27%	0.69%	10.43%
Revenue Q/Q Growth	3.56%	4.07%	2.66%
EBITDA Q/Q Growth	35.07%	25.46%	-21.86%
EBIT Q/Q Growth	169.57%	30.97%	-26.14%
NOPAT Q/Q Growth	633.02%	36.32%	-31.97%
Net Income Q/Q Growth	703.48%	40.09%	-31.39%
EPS Q/Q Growth	500.00%	36.36%	-29.41%
Operating Cash Flow Q/Q Growth	19.09%	35.61%	-36.27%
Free Cash Flow Firm Q/Q Growth	4.05%	50.73%	-66.92%
Invested Capital Q/Q Growth	3.25%	1.76%	8.28%
Profitability Metrics	-	-	-
Gross Margin	18.92%	26.51%	26.00%
EBITDA Margin	3.59%	12.61%	9.35%
Operating Margin	1.66%	10.61%	7.41%
EBIT Margin	1.49%	10.64%	7.53%
Profit (Net Income) Margin	0.65%	7.10%	4.83%
Tax Burden Percent	50.19%	68.27%	64.61%
Interest Burden Percent	87.33%	97.75%	99.25%
Effective Tax Rate	49.81%	31.73%	35.39%
Return on Invested Capital (ROIC)	2.44%	23.30%	17.02%
ROIC Less NNEP Spread (ROIC-NNEP)	-686.66%	28.92%	16.47%
Return on Net Nonoperating Assets (RNNOA)	-0.53%	-2.25%	-3.38%
Return on Equity (ROE)	1.91%	21.05%	13.64%
Cash Return on Invested Capital (CROIC)	-2.70%	22.61%	7.11%
Operating Return on Assets (OROA)	3.01%	22.61%	16.35%
Return on Assets (ROA)	1.32%	15.09%	10.48%
Return on Common Equity (ROCE)	1.91%	21.05%	13.64%
Return on Equity Simple (ROE_SIMPLE)	1.94%	18.81%	12.55%
Net Operating Profit after Tax (NOPAT)	1.18	12	8.95
NOPAT Margin	0.83%	7.25%	4.79%
Net Nonoperating Expense Percent (NNEP)	689.10%	-5.62%	0.56%
Return On Investment Capital (ROIC_SIMPLE)	-	18.37%	12.45%
Cost of Revenue to Revenue	81.08%	73.49%	74.00%
SG&A Expenses to Revenue	16.88%	15.55%	18.30%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	17.26%	15.89%	18.59%
Earnings before Interest and Taxes (EBIT)	2.11	17	14
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	5.08	20	17
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	1.81	3.26	5.11
Price to Tangible Book Value (P/TBV)	3.03	4.71	6.82
Price to Revenue (P/Rev)	0.61	1.23	1.97
Price to Earnings (P/E)	93.07	17.33	40.71
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	1.07%	5.77%	2.46%
Enterprise Value to Invested Capital (EV/IC)	1.77	3.73	6.36
Enterprise Value to Revenue (EV/Rev)	0.62	1.17	1.88
Enterprise Value to EBITDA (EV/EBITDA)	17.33	9.24	20.09
Enterprise Value to EBIT (EV/EBIT)	41.77	10.95	24.92
Enterprise Value to NOPAT (EV/NOPAT)	74.69	16.08	39.19
Enterprise Value to Operating Cash Flow (EV/OCF)	22.09	11.01	27.06
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	16.56	93.84
Leverage & Solvency	-	-	-
Debt to Equity	0.14	0.05	0.00
Long-Term Debt to Equity	0.11	0.02	0.00
Financial Leverage	0.00	-0.08	-0.21
Leverage Ratio	1.45	1.39	1.30
Compound Leverage Factor	1.26	1.36	1.29
Debt to Total Capital	12.03%	4.33%	0.00%
Short-Term Debt to Total Capital	2.31%	1.98%	0.00%
Long-Term Debt to Total Capital	9.72%	2.35%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%
Common Equity to Total Capital	87.97%	95.67%	100.00%
Debt to EBITDA	1.28	0.14	0.00
Net Debt to EBITDA	0.41	-0.52	0.00
Long-Term Debt to EBITDA	1.03	0.07	0.00
Debt to NOPAT	5.52	0.24	0.00
Net Debt to NOPAT	1.75	-0.90	0.00
Long-Term Debt to NOPAT	4.46	0.13	0.00
Altman Z-Score	5.91	9.67	15.94
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	2.07	2.30	2.81
Quick Ratio	1.22	1.63	2.07
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	-1.31	11	3.74
Operating Cash Flow to CapEx	115.60%	393.06%	193.98%
Free Cash Flow to Firm to Interest Expense	-4.89	29.33	35.59
Operating Cash Flow to Interest Expense	14.93	44.12	123.45
Operating Cash Flow Less CapEx to Interest Expense	2.02	32.89	59.81
Efficiency Ratios	-	-	-
Asset Turnover	2.02	2.13	2.17
Accounts Receivable Turnover	13.27	12.66	12.75
Inventory Turnover	12.81	12.56	15.55
Fixed Asset Turnover	6.90	7.33	7.53
Accounts Payable Turnover	15.73	13.11	13.57
Days Sales Outstanding (DSO)	27.52	28.82	28.62
Days Inventory Outstanding (DIO)	28.49	29.05	23.47
Days Payable Outstanding (DPO)	23.20	27.84	26.90
Cash Conversion Cycle (CCC)	32.80	30.03	25.20
Capital & Investment Metrics	-	-	-
Invested Capital	50	50	55
Invested Capital Turnover	2.93	3.22	3.55
Increase / (Decrease) in Invested Capital	2.49	0.34	5.21
Enterprise Value (EV)	88	187	351
Market Capitalization	86	197	367
Book Value per Share	$3.07	$4.11	$4.85
Tangible Book Value per Share	$1.83	$2.85	$3.63
Total Capital	54	63	72
Total Debt	6.50	2.73	0.00
Total Long-Term Debt	5.25	1.48	0.00
Net Debt	2.06	-10	-17
Capital Expenditures (CapEx)	3.45	4.31	6.68
Debt-free, Cash-free Net Working Capital (DFCFNWC)	11	9.63	11
Debt-free Net Working Capital (DFNWC)	15	23	28
Net Working Capital (NWC)	14	22	28
Net Nonoperating Expense (NNE)	0.25	0.24	-0.08
Net Nonoperating Obligations (NNO)	2.06	-10	-17
Total Depreciation and Amortization (D&A)	2.97	3.16	3.39
Debt-free, Cash-free Net Working Capital to Revenue	7.59%	6.02%	6.09%
Debt-free Net Working Capital to Revenue	10.73%	14.26%	15.04%
Net Working Capital to Revenue	9.84%	13.48%	15.04%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$0.06	$0.77	$0.61
Adjusted Weighted Average Basic Shares Outstanding	15.40M	14.67M	14.77M
Adjusted Diluted Earnings per Share	$0.06	$0.75	$0.60
Adjusted Weighted Average Diluted Shares Outstanding	15.72M	15.10M	15.13M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	14.64M	14.69M	15.20M
Normalized Net Operating Profit after Tax (NOPAT)	1.18	12	8.95
Normalized NOPAT Margin	0.83%	7.25%	4.79%
Pre Tax Income Margin	1.30%	10.40%	7.48%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	7.90	44.36	134.04
NOPAT to Interest Expense	4.42	30.22	85.23
EBIT Less CapEx to Interest Expense	-5.02	33.13	70.40
NOPAT Less CapEx to Interest Expense	-8.50	18.99	21.59
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	432.58%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Lifeway Foods' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	29.06%	15.70%	11.16%	17.14%	7.23%	17.45%	17.76%	25.30%	12.71%	11.50%
EBITDA Growth	11.66%	115.10%	959.07%	481.86%	204.28%	166.25%	95.73%	11.86%	-11.02%	-74.43%
EBIT Growth	14.75%	327.41%	237.33%	1,922.78%	323.36%	232.70%	146.81%	12.77%	-14.05%	-86.47%
NOPAT Growth	112.09%	921.47%	221.40%	1,953.78%	230.50%	366.48%	176.50%	18.42%	-17.38%	-103.67%
Net Income Growth	104.79%	869.89%	192.74%	2,530.00%	247.10%	454.33%	192.29%	19.87%	-12.78%	-104.03%
EPS Growth	100.00%	0.00%	200.00%	2,000.00%	283.33%	400.00%	166.67%	19.05%	-17.39%	0.00%
Operating Cash Flow Growth	88.77%	219.59%	567.13%	1,940.34%	60.48%	1,278.45%	-48.93%	169.52%	11.39%	-153.76%
Free Cash Flow Firm Growth	89.38%	70.73%	77.40%	126.81%	624.70%	325.55%	-54.29%	-36.12%	-58.22%	-246.14%
Invested Capital Growth	3.27%	5.27%	4.61%	2.80%	2.16%	0.69%	8.99%	5.19%	3.79%	10.43%
Revenue Q/Q Growth	13.88%	-6.04%	5.76%	3.50%	4.25%	2.93%	6.04%	10.13%	-6.23%	1.82%
EBITDA Q/Q Growth	99.69%	28.72%	-9.74%	150.79%	4.43%	12.63%	-33.64%	43.33%	-16.93%	-67.64%
EBIT Q/Q Growth	402.11%	45.46%	-16.70%	232.45%	5.09%	14.31%	-38.20%	51.90%	-19.90%	-82.01%
NOPAT Q/Q Growth	575.15%	-18.59%	3.75%	260.17%	8.65%	14.90%	-38.51%	54.26%	-24.21%	-105.10%
Net Income Q/Q Growth	719.17%	-27.16%	15.92%	280.24%	8.11%	16.32%	-38.88%	55.94%	-21.33%	-105.38%
EPS Q/Q Growth	500.00%	-16.67%	20.00%	250.00%	9.52%	8.70%	-36.00%	56.25%	-24.00%	0.00%
Operating Cash Flow Q/Q Growth	3,402.52%	-91.65%	769.83%	-19.79%	175.49%	-28.29%	-67.77%	323.29%	13.86%	-134.61%
Free Cash Flow Firm Q/Q Growth	93.16%	-248.45%	20.62%	241.68%	33.88%	49.79%	-154.30%	158.66%	-12.44%	-623.98%
Invested Capital Q/Q Growth	-2.60%	3.25%	-0.18%	2.40%	-3.20%	1.76%	8.05%	-1.17%	-4.50%	8.28%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	19.90%	22.10%	21.70%	28.75%	27.25%	28.01%	25.84%	27.01%	25.74%	25.35%
EBITDA Margin	5.02%	6.88%	5.87%	14.22%	14.25%	15.59%	9.76%	12.70%	11.25%	3.58%
Operating Margin	3.13%	5.47%	3.79%	12.15%	12.32%	13.67%	7.98%	10.96%	9.09%	1.52%
EBIT Margin	3.12%	4.83%	3.80%	12.22%	12.32%	13.68%	7.97%	11.00%	9.39%	1.66%
Profit (Net Income) Margin	2.58%	2.00%	2.19%	8.04%	8.34%	9.43%	5.44%	7.70%	6.46%	-0.34%
Tax Burden Percent	88.32%	43.79%	62.03%	67.36%	69.22%	69.67%	69.16%	70.59%	68.79%	-20.62%
Interest Burden Percent	93.53%	94.45%	92.79%	97.73%	97.84%	98.92%	98.57%	99.13%	99.91%	99.61%
Effective Tax Rate	11.68%	56.21%	37.97%	32.64%	30.78%	30.33%	30.84%	29.41%	31.21%	120.62%
Return on Invested Capital (ROIC)	8.00%	7.01%	7.06%	24.71%	27.01%	30.62%	17.80%	26.27%	22.74%	-1.11%
ROIC Less NNEP Spread (ROIC-NNEP)	10.93%	-380.01%	71.03%	33.92%	28.65%	31.54%	18.68%	26.51%	22.05%	-1.02%
Return on Net Nonoperating Assets (RNNOA)	-0.54%	-0.29%	-0.14%	-0.40%	-2.50%	-2.45%	-1.46%	-3.55%	-4.74%	0.21%
Return on Equity (ROE)	7.45%	6.72%	6.92%	24.32%	24.51%	28.16%	16.34%	22.72%	17.99%	-0.90%
Cash Return on Invested Capital (CROIC)	-2.88%	-2.70%	1.69%	9.36%	15.38%	22.61%	16.84%	21.38%	22.58%	7.11%
Operating Return on Assets (OROA)	5.92%	9.78%	7.81%	26.13%	24.65%	29.08%	17.35%	24.75%	19.95%	3.60%
Return on Assets (ROA)	4.89%	4.04%	4.50%	17.20%	16.69%	20.04%	11.82%	17.32%	13.71%	-0.74%
Return on Common Equity (ROCE)	7.45%	6.72%	6.92%	24.32%	24.51%	28.16%	16.34%	22.72%	17.99%	-0.90%
Return on Equity Simple (ROE_SIMPLE)	0.23%	0.00%	5.43%	10.90%	14.49%	0.00%	20.40%	19.99%	18.39%	0.00%
Net Operating Profit after Tax (NOPAT)	1.06	0.86	0.89	3.21	3.49	4.01	2.46	3.80	2.88	-0.15
NOPAT Margin	2.77%	2.40%	2.35%	8.18%	8.53%	9.52%	5.52%	7.73%	6.25%	-0.31%
Net Nonoperating Expense Percent (NNEP)	-2.93%	387.03%	-63.97%	-9.20%	-1.64%	-0.93%	-0.89%	-0.24%	0.69%	-0.10%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	6.34%	-	-	-	-0.20%
Cost of Revenue to Revenue	80.10%	77.90%	78.30%	71.25%	72.75%	71.99%	74.16%	72.99%	74.26%	74.65%
SG&A Expenses to Revenue	16.41%	16.25%	17.55%	16.26%	14.60%	14.03%	17.56%	15.77%	16.36%	23.54%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	16.76%	16.63%	17.91%	16.60%	14.93%	14.35%	17.86%	16.05%	16.66%	23.83%
Earnings before Interest and Taxes (EBIT)	1.19	1.73	1.44	4.79	5.04	5.76	3.56	5.41	4.33	0.78
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1.92	2.47	2.23	5.58	5.83	6.56	4.36	6.24	5.19	1.68
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.76	1.81	1.81	1.84	2.71	3.26	3.98	2.76	5.36	5.11
Price to Tangible Book Value (P/TBV)	2.84	3.03	2.97	2.88	4.07	4.71	5.61	3.78	7.19	6.82
Price to Revenue (P/Rev)	0.65	0.61	0.61	0.64	0.99	1.23	1.52	1.06	2.11	1.97
Price to Earnings (P/E)	770.80	93.07	33.39	16.89	18.70	17.33	19.52	13.82	29.15	40.71
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.13%	1.07%	2.99%	5.92%	5.35%	5.77%	5.12%	7.24%	3.43%	2.46%
Enterprise Value to Invested Capital (EV/IC)	1.79	1.77	1.80	1.86	2.95	3.73	4.51	3.25	7.12	6.36
Enterprise Value to Revenue (EV/Rev)	0.63	0.62	0.61	0.63	0.94	1.17	1.46	0.98	1.99	1.88
Enterprise Value to EBITDA (EV/EBITDA)	22.92	17.33	11.80	7.76	9.00	9.24	10.90	7.53	16.24	20.09
Enterprise Value to EBIT (EV/EBIT)	110.24	41.77	19.40	10.33	11.14	10.95	12.71	8.76	19.04	24.92
Enterprise Value to NOPAT (EV/NOPAT)	536.01	74.69	29.76	15.59	17.02	16.08	18.48	12.58	27.58	39.19
Enterprise Value to Operating Cash Flow (EV/OCF)	25.75	22.09	11.65	9.48	11.59	11.01	15.75	8.85	17.84	27.06
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	109.27	20.18	19.39	16.56	27.93	15.56	32.12	93.84
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.13	0.14	0.12	0.12	0.10	0.05	0.04	0.00	0.00	0.00
Long-Term Debt to Equity	0.11	0.11	0.10	0.09	0.08	0.02	0.02	0.00	0.00	0.00
Financial Leverage	-0.05	0.00	0.00	-0.01	-0.09	-0.08	-0.08	-0.13	-0.22	-0.21
Leverage Ratio	1.45	1.45	1.46	1.40	1.44	1.39	1.37	1.31	1.34	1.30
Compound Leverage Factor	1.35	1.37	1.35	1.36	1.41	1.38	1.35	1.30	1.34	1.30
Debt to Total Capital	11.41%	12.03%	10.97%	10.33%	9.33%	4.33%	3.76%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	1.75%	2.31%	1.83%	2.15%	2.02%	1.98%	1.89%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	9.65%	9.72%	9.14%	8.18%	7.30%	2.35%	1.87%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	88.59%	87.97%	89.03%	89.68%	90.67%	95.67%	96.24%	100.00%	100.00%	100.00%
Debt to EBITDA	1.73	1.28	0.79	0.49	0.36	0.14	0.11	0.00	0.00	0.00
Net Debt to EBITDA	-0.65	0.41	0.11	-0.12	-0.43	-0.52	-0.43	0.00	0.00	0.00
Long-Term Debt to EBITDA	1.46	1.03	0.66	0.39	0.28	0.07	0.06	0.00	0.00	0.00
Debt to NOPAT	40.43	5.52	2.00	0.99	0.68	0.24	0.19	0.00	0.00	0.00
Net Debt to NOPAT	-15.11	1.75	0.27	-0.24	-0.81	-0.90	-0.72	0.00	0.00	0.00
Long-Term Debt to NOPAT	34.21	4.46	1.67	0.78	0.53	0.13	0.09	0.00	0.00	0.00
Altman Z-Score	5.49	5.89	5.88	6.62	7.30	9.21	11.54	10.49	15.29	15.45
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.18	2.07	2.00	2.44	2.25	2.30	2.53	2.83	2.68	2.81
Quick Ratio	1.41	1.22	1.25	1.55	1.57	1.63	1.82	2.10	2.04	2.07
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-0.47	-1.63	-1.29	1.83	2.45	3.67	-1.99	1.17	1.02	-5.36
Operating Cash Flow to CapEx	463.63%	41.43%	171.79%	1,064.91%	578.63%	398.42%	62.62%	455.71%	488.27%	-206.16%
Free Cash Flow to Firm to Interest Expense	-6.06	-16.94	-12.41	16.78	22.46	59.15	-39.04	24.85	255.69	-1,786.34
Operating Cash Flow to Interest Expense	54.13	3.63	29.11	22.28	61.37	77.37	30.31	139.23	1,862.75	-859.67
Operating Cash Flow Less CapEx to Interest Expense	42.45	-5.13	12.16	20.18	50.76	57.95	-18.10	108.68	1,481.25	-1,276.67
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.90	2.02	2.05	2.14	2.00	2.13	2.18	2.25	2.12	2.17
Accounts Receivable Turnover	12.82	13.27	12.44	13.94	12.51	12.66	12.34	13.68	13.69	12.75
Inventory Turnover	13.34	12.81	12.92	12.82	12.46	12.56	13.90	14.24	15.03	15.55
Fixed Asset Turnover	6.60	6.90	6.93	7.15	7.13	7.33	7.14	7.53	7.49	7.53
Accounts Payable Turnover	13.17	15.73	12.98	18.69	12.66	13.11	12.63	17.28	13.21	13.57
Days Sales Outstanding (DSO)	28.48	27.52	29.34	26.18	29.18	28.82	29.59	26.68	26.67	28.62
Days Inventory Outstanding (DIO)	27.35	28.49	28.24	28.46	29.30	29.05	26.25	25.63	24.28	23.47
Days Payable Outstanding (DPO)	27.72	23.20	28.13	19.53	28.84	27.84	28.89	21.12	27.64	26.90
Cash Conversion Cycle (CCC)	28.12	32.80	29.46	35.11	29.64	30.03	26.95	31.19	23.31	25.20
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	48	50	50	51	49	50	54	53	51	55
Invested Capital Turnover	2.89	2.93	3.00	3.02	3.17	3.22	3.22	3.40	3.64	3.55
Increase / (Decrease) in Invested Capital	1.52	2.49	2.18	1.38	1.04	0.34	4.46	2.63	1.86	5.21
Enterprise Value (EV)	86	88	89	95	145	187	243	173	363	351
Market Capitalization	89	86	88	96	152	197	253	188	383	367
Book Value per Share	$3.26	$3.07	$3.33	$3.56	$3.82	$4.11	$4.32	$4.62	$4.84	$4.85
Tangible Book Value per Share	$2.01	$1.83	$2.03	$2.27	$2.54	$2.85	$3.07	$3.38	$3.61	$3.63
Total Capital	57	54	55	58	62	63	66	68	72	72
Total Debt	6.50	6.50	6.01	6.01	5.76	2.73	2.49	0.00	0.00	0.00
Total Long-Term Debt	5.50	5.25	5.01	4.76	4.51	1.48	1.24	0.00	0.00	0.00
Net Debt	-2.43	2.06	0.80	-1.44	-6.87	-10	-9.54	-15	-21	-17
Capital Expenditures (CapEx)	0.90	0.84	1.76	0.23	1.16	1.20	2.47	1.44	1.53	1.25
Debt-free, Cash-free Net Working Capital (DFCFNWC)	9.22	11	9.56	11	9.14	9.63	12	11	7.50	11
Debt-free Net Working Capital (DFNWC)	18	15	15	19	22	23	24	25	28	28
Net Working Capital (NWC)	17	14	14	18	21	22	23	25	28	28
Net Nonoperating Expense (NNE)	0.07	0.14	0.06	0.05	0.08	0.04	0.04	0.02	-0.09	0.01
Net Nonoperating Obligations (NNO)	-2.43	2.06	0.80	-1.44	-6.87	-10	-9.54	-15	-21	-17
Total Depreciation and Amortization (D&A)	0.73	0.73	0.78	0.79	0.79	0.80	0.80	0.84	0.86	0.90
Debt-free, Cash-free Net Working Capital to Revenue	6.75%	7.59%	6.57%	7.49%	5.94%	6.02%	7.15%	6.10%	4.12%	6.09%
Debt-free Net Working Capital to Revenue	13.28%	10.73%	10.16%	12.42%	14.15%	14.26%	14.36%	14.38%	15.42%	15.04%
Net Working Capital to Revenue	12.55%	9.84%	9.47%	11.60%	13.34%	13.48%	13.61%	14.38%	15.42%	15.04%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.06	$0.05	$0.06	$0.22	$0.23	$0.26	$0.17	$0.26	$0.20	($0.02)
Adjusted Weighted Average Basic Shares Outstanding	15.49M	15.40M	14.65M	14.65M	14.68M	14.67M	14.69M	14.73M	14.80M	14.77M
Adjusted Diluted Earnings per Share	$0.06	$0.05	$0.06	$0.21	$0.23	$0.25	$0.16	$0.25	$0.19	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	15.85M	15.72M	15.03M	15.08M	15.10M	15.10M	15.22M	15.20M	15.27M	15.13M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	15.50M	14.64M	14.66M	14.67M	14.69M	14.69M	14.71M	14.79M	14.82M	15.20M
Normalized Net Operating Profit after Tax (NOPAT)	1.06	1.37	0.89	3.21	3.49	4.01	2.46	3.80	2.88	0.50
Normalized NOPAT Margin	2.77%	3.83%	2.35%	8.18%	8.53%	9.52%	5.52%	7.73%	6.25%	1.06%
Pre Tax Income Margin	2.92%	4.56%	3.53%	11.94%	12.05%	13.53%	7.86%	10.90%	9.39%	1.65%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	15.45	18.03	13.87	43.98	46.22	92.89	69.78	115.02	1,082.50	259.67
NOPAT to Interest Expense	13.71	8.95	8.57	29.45	32.00	64.65	48.33	80.89	720.44	-49.00
EBIT Less CapEx to Interest Expense	3.78	9.28	-3.08	41.89	35.61	73.47	21.37	84.47	701.00	-157.33
NOPAT Less CapEx to Interest Expense	2.03	0.20	-8.37	27.36	21.40	45.23	-0.08	50.34	338.94	-466.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	432.58%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

Here are the key trend observations for Lifeway Foods (LWAY) based on quarterly statements from 2021 through 2024, with a focus on the latest four years of data provided (2021–2024). The analysis highlights topline, profitability, liquidity, and cash-flow dynamics that may interest retail investors.

Solid top-line stability in 2024: Revenue generally sits in the mid‑40s to high‑40s million range, with a peak around $49.2 million in Q2 2024, indicating resilient demand despite quarterly variability.
Core profitability stable across quarters: Gross margin remains in the 25%–28% band in 2024, suggesting consistent gross profitability despite quarterly mix shifts.
Operating income remained positive in most 2024 quarters: Q2 2024 and Q3 2024 show solid operating income (+$5.39m and +$4.19m respectively), signaling improving operating efficiency.
Net income broadly positive in 2024 (three of four quarters): 2024 saw positive net income in Q1, Q2, and Q3, indicating meaningful quarterly earnings power outside of one softer quarter.
Strong earnings per share in several quarters: Diluted EPS in 2024 ran around $0.16–$0.25 in several quarters (Q2: $0.25, Q3: $0.19, Q1: $0.16), reflecting earnings generation on a per-share basis.
Healthy balance sheet with minimal leverage: Long-term debt is typically zero across the periods, and total equity remains robust (around $71m–$72m by mid‑2024), supported by growing retained earnings.
Liquidity appears solid: Total current assets substantially exceed total current liabilities in 2024, implying a comfortable liquidity cushion for day‑to‑day operations and working capital needs.
Operating cash flow generally positive and improving in 2024: Net cash from continuing operating activities was positive in Q2 and Q3 2024 and contributed to overall cash generation in those periods.
Cash balance trend improves through 2024: Cash and equivalents rose across 2024, with levels near or above the low‑to‑mid teens at the start of the year and climbing toward the $20m range by mid‑2024, supporting near‑term liquidity needs.
Low debt service burden and modest financing costs: Interest expense remains very low, and cash interest paid is modest across quarters, which supports cash flow and earnings quality.

Quarterly revenue volatility reflects seasonality: While the 2024 topline remained solid, there is noticeable quarterly fluctuation that aligns with typical dairy/consumer‑staples seasonality, rather than a clear, consistent multi‑year growth trend.

Q4 2024 shows a quarterly net loss: Net income attributable to common shareholders was negative in Q4 2024 (approximately -$0.16m; EPS around -$0.02), indicating a softer quarter despite earlier strength.
Q4 2024 operating cash flow deteriorated: Net cash from continuing operating activities in Q4 2024 was negative, signaling a quarterly working capital drag despite prior positive quarters.
Financing cash outflows persisted into late 2024: Net cash from financing activities was negative in Q4 2024 (and other quarters), reflecting ongoing debt repayments and related cash outflows that reduce cash on hand even as operations remain cash‑generative in several quarters.

05/16/26 06:32 PM ETAI Generated. May Contain Errors.

Lifeway Foods Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Lifeway Foods' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

Lifeway Foods' net income appears to be on an upward trend, with a most recent value of $9.03 million in 2024, rising from $924 thousand in 2022. The previous period was $11.37 million in 2023. Check out Lifeway Foods' forecast to explore projected trends and price targets.

Lifeway Foods' total operating income in 2024 was $13.85 million, based on the following breakdown:

Total Gross Profit: $48.57 million
Total Operating Expenses: $34.72 million

Over the last 2 years, Lifeway Foods' total revenue changed from $141.57 million in 2022 to $186.82 million in 2024, a change of 32.0%.

Lifeway Foods' total liabilities were at $18.64 million at the end of 2024, a 12.2% decrease from 2023, and a 13.0% decrease since 2022.

In the past 2 years, Lifeway Foods' cash and equivalents has ranged from $4.44 million in 2022 to $16.73 million in 2024, and is currently $16.73 million as of their latest financial filing in 2024.

Over the last 2 years, Lifeway Foods' book value per share changed from 3.07 in 2022 to 4.85 in 2024, a change of 58.1%.

Related Companies

Financial statements for NASDAQ:LWAY last updated on 4/6/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lifeway Foods (LWAY) Financials

Financials Breakdown Chart

Key Financial Trends

Lifeway Foods Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Lifeway Foods (LWAY) Financials

Annual Income Statements for Lifeway Foods

Quarterly Income Statements for Lifeway Foods

Annual Cash Flow Statements for Lifeway Foods

Quarterly Cash Flow Statements for Lifeway Foods

Annual Balance Sheets for Lifeway Foods

Quarterly Balance Sheets for Lifeway Foods

Annual Metrics And Ratios for Lifeway Foods

Quarterly Metrics And Ratios for Lifeway Foods

Financials Breakdown Chart

Key Financial Trends

Lifeway Foods Financials - Frequently Asked Questions

When does Lifeway Foods' financial year end?

How has Lifeway Foods' net income changed over the last 2 years?

What is Lifeway Foods' operating income?

How has Lifeway Foods' revenue changed over the last 2 years?

How much debt does Lifeway Foods have?

How much cash does Lifeway Foods have?

How has Lifeway Foods' book value per share changed over the last 2 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools